Dec 25, 2024 · Personalized cancer vaccines could be available for some patient populations as soon as next year, one expert said in an interview with CURE®. “We are way closer than we ever thought [we would be] just like three years ago,” said Dr. Patrick Ott, director of the Center for Personal Vaccines, clinical director of the Melanoma Disease Center and director of clinical sciences of the Center ...

Oct 22, 2024 · Trodelvy received accelerated approval from the FDA in April 2021 for this specific indication, which was based on findings from the phase 2 TROPHY-U-01 study, which focused on findings related to the tumor response rate and duration of response. The FDA noted that the continued approval of Trodelvy for locally advanced or metastatic urothelial cancer would be contingent on the confirmatory ...

Dec 23, 2024 · Throughout 2024, the Food and Drug Administration (FDA) approved many cancer treatments, benefitting patients with different types of cancer. CURE compiled a list of the top FDA approval stories throughout the year, with diseases including gynecologic cancer, breast cancer, multiple myeloma and pancreatic cancer, among others.

Nov 3, 2021 · When a particular medicine stops working, “it’s just an expected part of the process and time to switch to something else,” says Dr. Arturo Loaiza-Bonilla, the National GI Program director and medical director of clinical research at Cancer Treatment Centers of America.

Dec 6, 2024 · Glossary. Five-fraction SBRT: targeted radiation therapy that requires sessions across five days, delivered every other day. Biochemical failure: when a lab test for prostate-specific antigen in prostate cancer shows a rise after treatment, which could mean the return of …

Feb 20, 2024 · Personalized cancer vaccines are on the horizon and could be available for some patient populations as soon as next year, one expert said. “We are way closer than we ever thought [we would be] just like three years ago,” said Dr. Patrick Ott, director of the Center for Personal Vaccines, clinical director of the Melanoma Disease Center and director of clinical sciences of the Center for ...

Nov 13, 2024 · Key Takeaways. Lymphedema risk varies significantly by cancer type and lymph node removal extent, necessitating personalized risk assessments. Misconceptions about lymphedema precautions, such as avoiding blood pressure checks on …

Nov 18, 2024 · Key Takeaways. COVID-19 RNA may induce monocytes to develop cancer-fighting properties, potentially shrinking tumors in certain metastatic cancers.

Dec 10, 2024 · Kisqali (ribociclib), a CDK4/6 inhibitor, has made significant strides in the treatment of HR-positive, HER2-negative early breast cancer, although several follow-up studies are being conducted to provide more information about its additional benefits and dosing strategies, experts said.

Nov 13, 2024 · Key Takeaways. TIL therapy uses a patient's own T cells, expanded in vitro, to target cancer cells, offering a personalized treatment approach. Amtagvi (lifileucel) is the first FDA-approved TIL therapy for advanced melanoma, marking a …